Kairos Pharma, LTD. (KAPA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2022: -$1.18M2023: -$2.08M2024: $4.78M2025: $6.34M$6.34M
2022Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$6.34M+32.8%
2024$4.78M+329.8%
2023-$2.08M-76.3%
2022-$1.18M